In the News | Friends of Cancer Research

You are here

In the News

March 13, 2019
The presence of comorbid conditions was associated with lower rates of clinical trial discussions between patients and their physicians, subsequently leading to decreased trial participation,... Read more
March 12, 2019
Friends of Cancer Research Applauds This Appointment The Secretary of Health and Human Services (HHS) Alex M. Azar III has appointed Dr. Norman E. Sharpless to be the acting Commissioner of the U.S.... Read more
March 12, 2019
National Cancer Institute Director Norman “Ned” Sharpless will become acting commissioner of the Food and Drug Administration, Health and Human Services Secretary Alex Azar said Tuesday.   Sharpless... Read more
March 12, 2019
The US Department of Health and Human Services (HHS) announced Tuesday that Dr. Ned Sharpless, current director of the National Cancer Institute (NCI) at the National Institutes of Health, will serve... Read more
March 12, 2019
Dr. Norman E. (Ned) Sharpless, director of the National Cancer Institute, will serve as acting commissioner of the Food and Drug Administration, Alex M. Azar III, secretary of health and human... Read more
March 12, 2019
It's official: NCI Director Ned Sharpless will take on the role of acting commissioner of the FDA. But what does the appointment mean for interagency cooperation between the federal government’s main... Read more
March 12, 2019
Executive Summary Norman Sharpless, director of the National Cancer Institute, will become acting FDA commissioner when Scott Gottlieb departs.   The US FDA's incoming acting commissioner shares an... Read more
March 12, 2019
U.S. President Donald Trump’s administration has tapped National Cancer Institute Director Norman Sharpless to serve as acting commissioner for the Food and Drug Administration, following the... Read more
March 12, 2019
Norman E. “Ned” Sharpless, the current head of the National Cancer Institute at the National Institutes of Health, will serve as the acting Food and Drug Administration Commissioner when Scott... Read more
March 12, 2019
Executive Summary Genentech/AbbVie drug becomes the seventh product known to be pilot-testing US FDA's new pathway; our infographic details the program's goals and how it has been used so far for... Read more

Pages